menu
    • menu

    Company profile for Lexicon pharmaceuticals

    NEW Drugs in Dev: 16
    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.

    Virtual Booth

    Contact Supplier

    Cosma S.p.A., part of CFM Group with AMSA & Clarochem, provides global pharma & veterinary health with 300+ tons of FDA-approved APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Lexicon Pharmaceuticals is a fully integrated biopharmaceutical company that is applying a unique approach to gene science based on Nobel Prize-winning technology to discover and develop precise medicines for people with serious, chronic conditions. Using a patient driven approach, we are working to discover and develop innovative medicines to safely and effectively treat disease and improve patient lives.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Lexicon pharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    8800 Technology Forest Place The Woodlands, Texas 77381-1160
    Telephone
    Telephone
    + 281-863-3000
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.lexpharma.com:443/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/lexicon-pharmaceuticals/?originalSubdomain=in
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/lexpharma?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Arab Health

    Arab Health

    Not Confirmed

    envelop Contact Supplier

    Arab Health

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Lexicon Sets $94.6M Public Offering Price With Private Placement
    Lexicon Sets $94.6M Public Offering Price With Private Placement

    30 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/30/3229250/0/en/Lexicon-Announces-Pricing-of-Approximately-94-6-Million-Public-Offering-and-Concurrent-Private-Placement.html

    GLOBENEWSWIRE
    30 Jan 2026
    Share Share
    Lexicon Announces Proposed Public Offering Of Common Stock
    Lexicon Announces Proposed Public Offering Of Common Stock

    29 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/29/3229137/0/en/Lexicon-Announces-Proposed-Public-Offering-of-Common-Stock.html

    GLOBENEWSWIRE
    29 Jan 2026
    Share Share
    Lexicon Pharma Marks 30Th Anniversary, Rings Nasdaq Closing Bell
    Lexicon Pharma Marks 30Th Anniversary, Rings Nasdaq Closing Bell

    23 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/23/3224764/0/en/Lexicon-Pharmaceuticals-to-Ring-the-Nasdaq-Closing-Bell-on-January-27-2026-to-Celebrate-30th-Anniversary.html

    GLOBENEWSWIRE
    23 Jan 2026
    Share Share
    Lexicon Opens Path to $1B+ Opportunity as FDA Greenlights Phase
    Lexicon Opens Path to $1B+ Opportunity as FDA Greenlights Phase

    22 Jan 2026

    // BIOSPACE

    https://www.biospace.com/drug-development/lexicon-opens-path-to-1b-opportunity-as-fda-greenlights-phase-iii-for-non-opioid-pill

    BIOSPACE
    22 Jan 2026
    Share Share
    Lexicon Pharma Gets Positive FDA EOP2 for Pilavapadin in DPN Pain
    Lexicon Pharma Gets Positive FDA EOP2 for Pilavapadin in DPN Pain

    21 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/21/3222788/0/en/Lexicon-Pharmaceuticals-Announces-Successful-End-of-Phase-2-Meeting-with-FDA-For-Pilavapadin-in-the-Treatment-of-Diabetic-Peripheral-Neuropathic-Pain.html

    GLOBENEWSWIRE
    21 Jan 2026
    Share Share
    Lexicon Pharma Updates Business And Pipeline At J.P. Morgan Conf
    Lexicon Pharma Updates Business And Pipeline At J.P. Morgan Conf

    12 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/12/3216775/0/en/Lexicon-Pharmaceuticals-Provides-a-Business-and-Pipeline-Update-at-the-44th-Annual-J-P-Morgan-Healthcare-Conference.html

    GLOBENEWSWIRE
    12 Jan 2026
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search